Aileron Therapeutics, Inc., a biopharmaceutical company that has defined a new class of drugs called Stapled Peptides, today announced that Tomi K. Sawyer, Ph.D., chief scientific officer and senior vice president, discovery & innovative technologies at Aileron, will give presentations on the company’s Stapled Peptides platform at several upcoming drug discovery and peptide-focused scientific conferences.